VolitionRX Ltd. | Mutual Funds
Mutual Funds that own VolitionRX Ltd.
Vanguard Extended Market Index Fund
288,752
0.96%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
100,890
0.34%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
80,000
0.27%
80,000
0.04%
12/31/2017
BlackRock Master Extended Market Index Series
6,405
0.02%
0
0%
01/31/2018
Vanguard Total Stock Market Index Trust
6,300
0.02%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
5,435
0.02%
0
0%
09/06/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
2,700
0.01%
0
0%
06/30/2018
| Address |
1 Scotts Road
Singapore CE 228208
Singapore
|
|
Employees
|
- |
| Website |
http://www.volitionrx.com |
| Updated |
07/08/2019 |
| VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Singapore. |
